Type Public (OAO) Industry Pharmaceuticals Headquarters Russia Net income 321.1 million USD (2012) | Traded as MCX: PHST
LSE: PHST Products Remedies Revenue 1.6 billion USD (2012) Founded 2003 | |
 | ||
Key people Viktor Vladimirovich Kharitonin,(Chairman)
Igor Konstantinovich Krylov, (CEO) Profit US$ 321.1 million (2012) CEO Grigory Potapov (18 Jun 2015–) Parent organization Augment Investments Limited Subsidiaries Lekko CJSC, ZAO Vindeksfarm, FF Lekko ZAO | ||
Pharmstandard russias leading pharma company
Pharmstandard is the leading Russian pharmaceutical company, it is headquartered in Dolgoprudny.
Pharmstandard portfolio includes over 200 products used in the treatment of diabetes, growth hormone deficiency, cardiovascular diseases, gastroenterological and neurological disorders, infectious diseases, cancer, etc. Over 90 products offered by Pharmstandard are included in the List of Vital Pharmaceutical Products.
The company has six manufacturing facilities located in Moscow, Ufa, Nizhny Novgorod, Kursk, Tomsk and Tyumen.
References
Pharmstandard Wikipedia(Text) CC BY-SA